𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study

✍ Scribed by E. Bosi; G. C. Ellis; C. A. Wilson; P. R. Fleck


Book ID
109046199
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
787 KB
Volume
13
Category
Article
ISSN
1462-8902

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A randomized, parallel group, double-bli
Liraglutide provides similar glycaemic c